{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:35Z","timestamp":1793413475084,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pmed.1004414","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000}}],"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1158722"],"award-info":[{"award-number":["GNT1158722"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1158722"],"award-info":[{"award-number":["GNT1158722"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1158722"],"award-info":[{"award-number":["GNT1158722"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1158722"],"award-info":[{"award-number":["GNT1158722"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1158722"],"award-info":[{"award-number":["GNT1158722"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1158722"],"award-info":[{"award-number":["GNT1158722"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1158722"],"award-info":[{"award-number":["GNT1158722"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Telethon New Children's Hospital Research Fund","award":["2012; Round 1"],"award-info":[{"award-number":["2012; Round 1"]}]},{"name":"Telethon New Children's Hospital Research Fund","award":["2012; Round 1"],"award-info":[{"award-number":["2012; Round 1"]}]},{"name":"Telethon New Children's Hospital Research Fund","award":["2012; Round 1"],"award-info":[{"award-number":["2012; Round 1"]}]},{"DOI":"10.13039\/501100020265","name":"Stan Perron Charitable Foundation","doi-asserted-by":"publisher","award":["Post PhD Career launching Award (2022)"],"award-info":[{"award-number":["Post PhD Career launching Award (2022)"]}],"id":[{"id":"10.13039\/501100020265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Department of Education and Training"},{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases"},{"DOI":"10.13039\/100015742","name":"Forrest Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2008911"],"award-info":[{"award-number":["GNT2008911"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Melbourne, Murdoch's Children's Research Institute, and the Royal Children's Hospital Foundation","id":[{"id":"https:\/\/ror.org\/00nxtdr22","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Medical Research Future Fund","award":["MRF1195153"],"award-info":[{"award-number":["MRF1195153"]}],"id":[{"id":"https:\/\/ror.org\/0513v5k17","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In many countries, infant vaccination with acellular pertussis (aP) vaccines has replaced use of more reactogenic whole-cell pertussis (wP) vaccines. Based on immunological and epidemiological evidence, we hypothesised that substituting the first aP dose in the routine vaccination schedule with wP vaccine might protect against IgE-mediated food allergy. We aimed to compare reactogenicity, immunogenicity, and IgE-mediated responses of a mixed wP\/aP primary schedule versus the standard aP-only schedule.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>OPTIMUM is a Bayesian, 2-stage, double-blind, randomised trial. In stage one, infants were assigned (1:1) to either a first dose of a pentavalent wP combination vaccine (DTwP-Hib-HepB, Pentabio PT Bio Farma, Indonesia) or a hexavalent aP vaccine (DTaP-Hib-HepB-IPV, Infanrix hexa, GlaxoSmithKline, Australia) at approximately 6 weeks old. Subsequently, all infants received the hexavalent aP vaccine at 4 and 6 months old as well as an aP vaccine at 18 months old (DTaP-IPV, Infanrix-IPV, GlaxoSmithKline, Australia). Stage two is ongoing and follows the above randomisation strategy and vaccination schedule. Ahead of ascertainment of the primary clinical outcome of allergist-confirmed IgE-mediated food allergy by 12 months old, here we present the results of secondary immunogenicity, reactogenicity, tetanus toxoid IgE-mediated immune responses, and parental acceptability endpoints. Serum IgG responses to diphtheria, tetanus, and pertussis antigens were measured using a multiplex fluorescent bead-based immunoassay; total and specific IgE were measured in plasma by means of the ImmunoCAP assay (Thermo Fisher Scientific). The immunogenicity of the mixed schedule was defined as being noninferior to that of the aP-only schedule using a noninferiority margin of 2\/3 on the ratio of the geometric mean concentrations (GMR) of pertussis toxin (PT)-IgG 1 month after the 6-month aP. Solicited adverse reactions were summarised by study arm and included all children who received the first dose of either wP or aP. Parental acceptance was assessed using a 5-point Likert scale. The primary analyses were based on intention-to-treat (ITT); secondary per-protocol (PP) analyses were also performed. The trial is registered with ANZCTR (ACTRN12617000065392p).<\/jats:p>\n                    <jats:p>Between March 7, 2018 and January 13, 2020, 150 infants were randomised (75 per arm). PT-IgG responses of the mixed schedule were noninferior to the aP-only schedule at approximately 1 month after the 6-month aP dose [GMR = 0\u00b798, 95% credible interval (0\u00b777 to 1\u00b726); probability (GMR &gt; 2\/3) &gt; 0\u00b799; ITT analysis]. At 7 months old, the posterior median probability of quantitation for tetanus toxoid IgE was 0\u00b722 (95% credible interval 0\u00b712 to 0\u00b734) in both the mixed schedule group and in the aP-only group. Despite exclusions, the results were consistent in the PP analysis. At 6 weeks old, irritability was the most common systemic solicited reaction reported in wP (65 [88%] of 74) versus aP (59 [82%] of 72) vaccinees. At the same age, severe systemic reactions were reported among 14 (19%) of 74 infants after wP and 8 (11%) of 72 infants after aP. There were 7 SAEs among 5 participants within the first 6 months of follow-up; on blinded assessment, none were deemed to be related to the study vaccines. Parental acceptance of mixed and aP-only schedules was high (71 [97%] of 73 versus 69 [96%] of 72 would agree to have the same schedule again).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared to the aP-only schedule, the mixed schedule evoked noninferior PT-IgG responses, was associated with more severe reactions, but was well accepted by parents. Tetanus toxoid IgE responses did not differ across the study groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Trial registered at the Australian and New Zealand Clinical 207 Trial Registry (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/ACTRN12617000065392p\" xlink:type=\"simple\">ACTRN12617000065392p<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1004414","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T13:43:31Z","timestamp":1718027011000},"page":"e1004414","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6629-1603","authenticated-orcid":true,"given":"Gladymar","family":"P\u00e9rez Chac\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8403-6075","authenticated-orcid":true,"given":"Marie J.","family":"Estcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9459-2566","authenticated-orcid":true,"given":"James","family":"Totterdell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5683-996X","authenticated-orcid":true,"given":"Kirsten P.","family":"Perrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0907-6963","authenticated-orcid":true,"given":"Dianne E.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire S.","family":"Waddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O\u2019 Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"McAlister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7562-7228","authenticated-orcid":true,"given":"Peter C.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4670-0638","authenticated-orcid":true,"given":"Tom","family":"Snelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"key":"pmed.1004414.ref001","first-page":"CD001478","article-title":"Acellular vaccines for preventing whooping cough in children.","volume":"2014","author":"L Zhang","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"pmed.1004414.ref002","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/S1473-3099(18)30646-7","article-title":"PERISCOPE: road towards effective control of pertussis","volume":"19","author":"DA Diavatopoulos","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"pmed.1004414.ref003","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jama.2012.6364","article-title":"Number and order of whole cell pertussis vaccines in infancy and disease protection","volume":"308","author":"SL Sheridan","year":"2012","journal-title":"JAMA"},{"key":"pmed.1004414.ref004","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMc1212006","article-title":"Priming with whole-cell versus acellular pertussis vaccine","volume":"368","author":"J Liko","year":"2013","journal-title":"N Engl J Med"},{"key":"pmed.1004414.ref005","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.jaip.2019.12.020","article-title":"Whole-cell pertussis vaccination and decreased risk of IgE-mediated food allergy: a nested case-control study","volume":"8","author":"MJ Estcourt","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"pmed.1004414.ref006","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaip.2023.12.048","article-title":"Infant whole-cell versus acellular pertussis vaccination in 1997 to 1999 and risk of childhood hospitalization for food-induced anaphylaxis: linked administrative databases cohort study","volume":"12","author":"G P\u00e9rez Chac\u00f3n","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"pmed.1004414.ref007","doi-asserted-by":"crossref","first-page":"e0291483","DOI":"10.1371\/journal.pone.0291483","article-title":"Association between pertussis vaccination in infancy and childhood asthma: a population-based record linkage cohort study.","volume":"18","author":"G P\u00e9rez Chac\u00f3n","year":"2023","journal-title":"PLoS ONE"},{"key":"pmed.1004414.ref008","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1172\/JCI121309","article-title":"Th1\/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters","volume":"128","author":"AR da Silva","year":"2018","journal-title":"J Clin Invest"},{"key":"pmed.1004414.ref009","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.vaccine.2006.06.046","article-title":"Modulation of the infant immune responses by the first pertussis vaccine administrations","volume":"25","author":"F Mascart","year":"2007","journal-title":"Vaccine"},{"key":"pmed.1004414.ref010","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/j.vaccine.2016.05.048","article-title":"Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP)\u2014Immunological curiosity or canary in the mine?","volume":"34","author":"PG Holt","year":"2016","journal-title":"Vaccine"},{"key":"pmed.1004414.ref011","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/pai.13113","article-title":"Further investigations of the IgE response to tetanus and diphtheria following covaccination with acellular rather than cellular Bordetella pertussis","volume":"30","author":"RC Aalberse","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"pmed.1004414.ref012","first-page":"6","article-title":"A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy","author":"AR da Silva","year":"2021","journal-title":"JCI Insight"},{"key":"pmed.1004414.ref013","doi-asserted-by":"crossref","first-page":"e042838","DOI":"10.1136\/bmjopen-2020-042838","article-title":"OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell\/acellular pertussis vaccine schedule","volume":"10","author":"G P\u00e9rez Chac\u00f3n","year":"2020","journal-title":"BMJ Open"},{"key":"pmed.1004414.ref014","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13063-021-05874-6","article-title":"Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell\/acellular pertussis vaccine schedule","volume":"23","author":"JA Totterdell","year":"2022","journal-title":"Trials"},{"key":"pmed.1004414.ref015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12887-015-0525-2","article-title":"The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule","volume":"15","author":"K Rusmil","year":"2015","journal-title":"BMC Pediatrics"},{"key":"pmed.1004414.ref016","volume-title":"Product Information: WHO Prequalified Vaccines","author":"Pentabio Bio Farma","year":"2022"},{"key":"pmed.1004414.ref017","unstructured":"Infanrix hexa. The Australian Immunisation Handbook. 2023 Jun 30. Available from: https:\/\/immunisationhandbook.health.gov.au\/vaccines\/infanrix-hexa [accessed 5 Apr 2024]."},{"key":"pmed.1004414.ref018","volume-title":"Australian Government Department of Health and Aged Care","author":"Australian Government Department of Health and Aged Care","year":"2023"},{"key":"pmed.1004414.ref019","article-title":"The Australian Immunisation Handbook","author":"IPV Infanrix","year":"2023"},{"key":"pmed.1004414.ref020","unstructured":"National Health and Medical Research Council. Safety monitoring and reporting in clinical trials involving therapeutic goods | NHMRC [Internet]. Available from: https:\/\/www.nhmrc.gov.au\/about-us\/publications\/safety-monitoring-and-reporting-clinical-trials-involving-therapeutic-goods [accessed 2024 Mar 29]."},{"key":"pmed.1004414.ref021","doi-asserted-by":"crossref","first-page":"101360","DOI":"10.1016\/j.mex.2021.101360","article-title":"Optimising a 6-plex tetanus-diphtheria-pertussis fluorescent bead-based immunoassay.","volume":"8","author":"SM McAlister","year":"2021","journal-title":"MethodsX."},{"key":"pmed.1004414.ref022","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.vaccine.2021.01.041","article-title":"An observational study of antibody responses to a primary or subsequent pertussis booster vaccination in Australian healthcare workers","volume":"39","author":"SM McAlister","year":"2021","journal-title":"Vaccine"},{"key":"pmed.1004414.ref023","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"SA Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"pmed.1004414.ref024","volume-title":"The immunological basis for immunization series: module 3: tetanus","author":"World Health Organization","year":"2018"},{"key":"pmed.1004414.ref025","volume-title":"Immunological basis for immunization: module 2: diphtheria\u2014update 2009.","author":"World Health Organization","year":"2009"},{"key":"pmed.1004414.ref026","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaci.2017.05.008","article-title":"ImmunoCAP assays: Pros and cons in allergology","volume":"140","author":"M van Hage","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"pmed.1004414.ref027","unstructured":"ImmunoCAP Total IgE. Thermo Fisher Scientific [Internet]. Available from: https:\/\/dfu.phadia.com\/Data\/Pdf\/5be5621c89c2320848d710f6.pdf [accessed 2024 Apr 25]."},{"key":"pmed.1004414.ref028","unstructured":"ImmunoCAP Specific IgE. Thermo Fisher Scientific [Internet]. Available from: https:\/\/dfu.phadia.com\/Data\/Pdf\/5dae9e2489c23208b8036206.pdf [accessed 2024 Apr 25]."},{"key":"pmed.1004414.ref029","unstructured":"World Health Organization expert committee on biological standardization. Guidelines on clinical evaluation of vaccines: regulatory expectations. Geneva; 2017. Report No.: 1004. Available from: https:\/\/www.who.int\/publications\/m\/item\/WHO-TRS-1004-web-annex-9 [accessed 2024 Mar 28]."},{"key":"pmed.1004414.ref030","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/infdis\/jit560","article-title":"Immune responses to pertussis vaccines and disease","volume":"209","author":"KM Edwards","year":"2014","journal-title":"J Infect Dis"},{"key":"pmed.1004414.ref031","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0264-410X(96)00112-0","article-title":"Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance","volume":"15","author":"E Miller","year":"1997","journal-title":"Vaccine"},{"key":"pmed.1004414.ref032","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1542\/peds.85.3.294","article-title":"Pennridge Pediatric Associates. Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy","volume":"85","author":"SS Long","year":"1990","journal-title":"Pediatrics"},{"key":"pmed.1004414.ref033","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.4161\/hv.28666","article-title":"A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I).","volume":"10","author":"R Prymula","year":"2014","journal-title":"Hum Vaccin Immunother."},{"key":"pmed.1004414.ref034","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(09)61208-3","article-title":"Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials","volume":"374","author":"R Prymula","year":"2009","journal-title":"Lancet Lond Engl"},{"key":"pmed.1004414.ref035","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.vaccine.2013.01.044","article-title":"Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol.","volume":"31","author":"R Prymula","year":"2013","journal-title":"Vaccine"},{"key":"pmed.1004414.ref036","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.vaccine.2015.10.136","article-title":"Pertussis vaccines: WHO position paper, August 2015\u2014Recommendations.","volume":"34","author":"World Health Organization","year":"2016","journal-title":"Vaccine"},{"key":"pmed.1004414.ref037","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis","volume":"334","author":"D Greco","year":"1996","journal-title":"N Engl J Med"},{"key":"pmed.1004414.ref038","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine","volume":"334","author":"L Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"key":"pmed.1004414.ref039","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/cid\/ciz199","article-title":"National outbreak of pertussis in England, 2011\u20132012: a case-control study comparing 3-component and 5-component acellular vaccines with whole-cell pertussis vaccines","volume":"70","author":"CFA Carvalho","year":"2020","journal-title":"Clin Infect Dis"},{"key":"pmed.1004414.ref040","doi-asserted-by":"crossref","first-page":"E399","DOI":"10.1503\/cmaj.160193","article-title":"Effectiveness of pertussis vaccination and duration of immunity","volume":"188","author":"KL Schwartz","year":"2016","journal-title":"CMAJ"},{"key":"pmed.1004414.ref041","first-page":"CD013682","article-title":"Whole-cell pertussis vaccine in early infancy for the prevention of allergy in children","volume":"9","author":"G P\u00e9rez Chac\u00f3n","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"pmed.1004414.ref042","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1081-1206(10)60534-0","article-title":"Influence of dose and frequency of antigen injection on IgE development in young children: a comparison of fire ant stings and tetanus immunizations","volume":"103","author":"DR Ownby","year":"2009","journal-title":"Ann Allergy Asthma Immunol"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1004414","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T15:27:51Z","timestamp":1719329271000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004414"}},"subtitle":[],"editor":[{"given":"James G.","family":"Beeson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004414","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.20.23300336","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]}}}